Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors

NCT01417546 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01417546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First In-Human Phase I Trial of NHS-IL12 in Patients With Metastatic Solid Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
December 12, 2011
Completion date
October 14, 2021
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial neoplasms, malignant, epithelial tumors, malignant, malignant mesenchymal tumor